Amgen

The 5 pharma vets and 3 newcomers that made BCG's '50 most innovative' firms list
BioPharma Dive
Fri, 12/4/15 - 08:26 pm
Gilead Sciences
Biogen
Roche
Bayer
JNJ
Amgen
innovation
Amgen and Merck & Co to Collaborate for Immunotherapy Cancer
Bidness, ETC
Fri, 12/4/15 - 08:20 pm
Amgen
Merck
Keytruda
cancer immunotherapy
Blincyto
The 3 Most Important Drugs in Amgen's Pipeline
Motley Fool
Fri, 12/4/15 - 08:17 pm
Amgen
ABP 501
Omecamtiv Mecarbil
Kyprolis
Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Yahoo
Fri, 12/4/15 - 01:40 pm
Amgen
biosimilars
Europe
Humira
ABP 501
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Alzheimer's disease
Amgen
AstraZeneca
BACE inhibitors
Eli Lilly
Merck
Novartis
Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?
Seeking Alpha
Wed, 12/2/15 - 09:27 am
Repatha
Praluent
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
patents
UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug
Bloomberg
Tue, 12/1/15 - 10:16 am
Unitedhealth Group
Sanofi
Regeneron
Amgen
Praluent
Repatha
Why AbbVie was not Impacted by Amgen Humira Biosimilar Submission
Bidness, ETC
Mon, 11/30/15 - 09:27 am
AbbVie
Humira
Amgen
biosimilars
ABP 501
Amgen applies to FDA for competitor drug to AbbVie's Humira
Marketwatch
Wed, 11/25/15 - 06:43 pm
Amgen
FDA
AbbVie
Humira
biosimilars
psoriasis
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
CVS Chooses Repatha as New Cholesterol Drug for Caremark
WSJ Online
Mon, 11/23/15 - 09:35 am
CVS Caremark
Amgen
Repatha
Sanofi
Regeneron
Praluent
Biogen and Samsung's Enbrel biosimilar wins EMA nod for EU approval
Fierce Pharma
Fri, 11/20/15 - 06:21 pm
Biogen
Samsung
Enbrel
biosimilars
Europe
Pfizer
Amgen
anti-TNF
Big pharma trying to quash CA drug price cap effort with massive campaign war chest
BioPharma Dive
Fri, 11/20/15 - 10:55 am
California
drug pricing
JNJ
AbbVie
Amgen
Eli Lilly
Bristol-Myers Squibb
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Thu, 11/19/15 - 04:39 pm
Amgen
Regeneron
Medicines Company
Isis Pharmaceuticals
Gilead Sciences
Biogen
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Fierce Pharma
Wed, 11/18/15 - 10:15 pm
Amgen
Repatha
NICE
UK
PCSK9 inhibitors
Is Allergan-Amgen Merger Possible?
Bidness, ETC
Wed, 11/18/15 - 09:55 am
Allergan
Amgen
M&A
Pfizer
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Novartis
Amgen
biosimilars
Neulasta
Sandoz
Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Fierce Biotech
Fri, 11/13/15 - 10:00 am
Novartis
Roche
Pharma CEOs
Amgen
Repatha
Joe Jimenez
Severin Schwan
Why Amgen, Inc Should Acquire Alnylam
Bidness, ETC
Thu, 11/12/15 - 09:25 am
Amgen
Alnylam
M&A
ALN-PCSsc
Medicines Company
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Fierce Biotech
Wed, 11/11/15 - 10:04 am
Amgen
Humira
biosimilars
rheumatoid arthritis

Pages